Filter
865
Text search:
pharmaceutical
procurement
Featured
Recommendations
92
New Publications
265
Language
Document type
No document type
430
Studies & Reports
178
Guidelines
131
Strategic & Response Plan
54
Manuals
41
Fact sheets
13
Training Material
8
Situation Updates
6
Resource Platforms
3
Infographics
1
Countries / Regions
Ethiopia
48
Kenya
43
Global
30
Uganda
27
India
26
Sierra Leone
23
Nigeria
23
South Africa
21
Liberia
20
Namibia
19
Ghana
18
Tanzania
18
Malawi
17
Rwanda
16
Nepal
15
Western and Central Europe
15
Zambia
14
Zimbabwe
12
Ukraine
12
Africa
11
Philippines
10
Bangladesh
10
Lesotho
10
Latin America and the Carribbean
9
Eastern Europe
8
Cambodia
7
Senegal
6
Indonesia
6
Myanmar / Burma
6
Burkina Faso
5
Congo, Democratic Republic of
5
Syria
5
Benin
5
Botswana
5
Asia
5
Cameroon
4
Eswatini/ Swaziland
4
South–East Asia Region
4
Haiti
3
Mozambique
3
Papua New Guinea
3
Sudan
3
West and Central Africa
3
North America
3
Guinea
2
Jordan
2
Thailand
2
East and Southern Africa
2
Western Pacific Region
2
Albania
2
Mali
1
Saudi Arabia
1
Somalia
1
South Sudan
1
Germany
1
Central African Republic
1
Brazil
1
North Macedonia
1
Libya
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Paraguay
1
Fiji
1
Southern Africa
1
Laos
1
Timor Leste/ East Timor
1
Tajikistan
1
Russia
1
Moldova
1
Vietnam
1
Gabon
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
441
Clinical Guidelines
50
Key Resources
38
Public Health
33
Pharmacy & Technologies
24
Women & Child Health
15
Capacity Building
3
Annual Report MEDBOX
1
Toolboxes
Pharmacy
100
AMR
89
COVID-19
54
HIV
49
TB
44
NTDs
20
Health Financing Toolbox
17
Conflict
14
Rapid Response
14
NCDs
14
Malaria
14
Global Health Education
11
Planetary Health
11
Ebola & Marburg
10
Mental Health
9
Caregiver
7
Natural Hazards
4
2.0 Rapid Response
4
Disability
2
Cholera
2
Polio
2
Refugee
2
Zika
2
Specific Hazards
1
WHO Technical Report Series, No. 961, 2011, Annex 8 - These guidelines are intended to provide a description of ways in which pharmacists can improve access to health care, health promotion and the use of medicines on behalf of the patients they serve. The role of FIP is to provide leadership for na
...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically
...
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceutica
...
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of
...
World Journal of Pharmaceutical and Medical Research vol. 5 (2019) 3, 129-132
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the pop
...
Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health. Submitted to the United Nations Children’s Fund by JSI, Arlington, VA: JSI Research & Training Institute, Inc.
...
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan
...
This resource offers practical guidance in managing the supply chain, with emphasis on health comodities. The handbook is particularly useful for program managers who design, manage, and assess logistics system for health program. The document includes detailed information about the design and imple
...
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to m
...
The WHO Model List of Essential Medicines and Model List of Essential Medicines for Children are updated and published every two years, intended as a guide for countries or regional authorities to adopt or adapt in accordance with local priorities and treatment guidelines for the development and upd
...
Severe Acute Malnutrition (SAM) is one of the greatest child survival challenges in the world today and
reportedly affects more than 16.2 million children each year1. High impact, proven treatment interventions exist
yet sadly approximately only 3.2 million children with SAM have access to treatme
...
Essential Medicines are those that satisfy the priority health care needs of the population. They are selected with due regard to public health relevance, evidence on efficacy, safety and comparative cost-effectiveness. This edition of the Essential Medicines List (EML) 2017 for Ghana has been deriv
...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and
...
Interagency Guidelines - This revised Interagency List of Essential Medicines for Reproductive Health presents
the current international consensus on rational selection of essential reproductive health medicines. The list is intended to support decisions regarding the production, quality assurance
...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covi
...
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a national medicine quality control laborato
...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells
...
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults,
...
